The disagreement stems from a section of the licensing agreement stating in paragraph two the royalty rate will not exceed a half-percent for products that "detect Lyme disease in combination with one other veterinary diagnostic test," but paragraph three states a royalty rate of 2.5% for products that "detect Lyme disease in combination with one or more veterinary diagnostic products."
January 11, 2024 at 03:18 PM
4 minute read
The University of Texas System is hoping the Texas Supreme Court can reverse an appellate court ruling that threw out a $51 million judgment in a royalty rate dispute with IDEXX Laboratories Inc.
The parties came before the court this week for oral arguments concerning a licensing agreement signed in 1999 related to Lyme disease detection patents controlled by the Board of Regents of the UT System.
Phila. Jury Hands Up $6.1M Verdict to Crushed Worker Despite Plaintiff's 'Nuclear' Settlement Demand
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
The Texas Lawyer honors attorneys and judges who have made a remarkable difference in the legal profession in Texas.
The premier educational and networking event for employee benefits brokers and agents.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
